This is a service of EIN News a digital news provider
Sunday November 8, 2009
Healthcare Industry Today
Sign up for a free trial
Register Now
Member center Log In
Actos News is an EIN News Service for health professionals. Constantly updated news and information about health.
FORMATS: RSS | EMAIL

Latest Actos News

Sort by: relevance (24 hours) relevance date
  • Obesity Drug Deal Worth $1B for Amylin 2 Nov 2009 18:13 GMT
    ... Obesity Drug Deal Potentially Worth $1B for Amylin Amylin ... collaboration to advance more options in obesity treatment more quickly than either company could do ... expire on some of its best-selling drugs. Actos, a $4 billion drug, threatens to leave ...

  • Obesity Drug Deal Potentially Worth $1B for Amylin 2 Nov 2009 19:13 GMT
    ... Obesity Drug Deal Potentially Worth $1B for Amylin Amylin ... collaboration to advance more options in obesity treatment more quickly than either company could do ... expire on some of its best-selling drugs. Actos, a $4 billion drug, threatens to leave ...

  • FDA update on BYETTA injection: Amylin Pharmaceuticals and Eli Lilly respond 3 Nov 2009 09:26 GMT
    ... Amylin Pharmaceuticals, Inc., and Eli Lilly and Company (NYSE: ... (NASDAQ:SLXP) today announced the U.S. Food and Drug Administration (FDA... Takeda Pharmaceutical Company Limited ("Takeda") today ... three studies show the oral anti-diabetic agent ACTOS (R) (pioglitazone HCl), in combinat... The opinions ...

  • UPDATE 1-Takeda, Amylin to co-develop obesity drugs 2 Nov 2009 01:11 GMT
    ... * Worldwide agreement to co-develop obesity drugs * Amylin to receive $75 mln up-front * Milestone ... TOKYO, Nov 2 (Reuters) - Japan's Takeda Pharmaceutical ( ) said on Monday they will ... and best known for its diabetes drug Actos, will pay Amylin $75 million in a ...

  • Takeda, Amylin to co-develop obesity drugs 2 Nov 2009 01:36 GMT
    ... on Monday they will co-develop and commercialize drugs to treat obesity, including two Amylin drugs in mid-stage trials. Takeda, Japan's biggest drugmaker and best known ... and best known for its diabetes drug Actos, will pay Amylin $75 million in a ...

  • Reportlinker Adds Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes 3 Nov 2009 17:11 GMT
    ... leading antidiabetic therapies, 2009 58 Table 7: Actos (pioglitazone) - Drug profile, 2009 60 Table 8: Impacting factors ... two insulin injection regimens 52 Figure 14: Treatment tree as recommended by the 2008/09 edition ...

  • Reportlinker Adds Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel 3 Nov 2009 17:16 GMT
    ... leading antidiabetic therapies, 2009 58 Table 7: Actos (pioglitazone) - Drug profile, 2009 60 Table 8: Impacting factors ... two insulin injection regimens 52 Figure 14: Treatment tree as recommended by the 2008/09 edition ...

  • Takeda signs obesity deal with Amylin worth over $1 billion 2 Nov 2009 12:36 GMT
    ... to develop and commercialise products for the treatment of obesity “and related indications”. The deal ... Yasuchika Hasegawa, chief executive of the Japanese drugmaker, said that by leveraging his firm's “global ... currency. Takeda’s biggest earner, the diabetes drug Actos (pioglitazone), brought in 194.80 billion yen, down ...

  • NASH Patients Perk Up with Vitamin E 6 Nov 2009 15:15 GMT
    ... BOSTON -- Vitamin E and, potentially, pioglitazone (Actos) may become the first effective treatments for non-alcoholic steatohepatitis (NASH), a researcher said ... bariatric surgery, or a recent history of drug therapy for NASH. Patients were randomized to ...

  • Landis+Gyr concluye la captación de accionistas por un valor de 100 millones de dólares 6 Nov 2009 16:11 GMT
    ... todo el país de los sistemas de medición inteligentes. Similares medidas y regulaciones gubernamentales dispuestas ... que puede integrar, de modo inteligente, los actos de todos los usuarios conectadas a ella, ...

  • Takeda holds forecast, drugs outlook still tough 30 Oct 2009 13:59 GMT
    ... sales in markets, falling sales in flagship drugs * Shares up 3.4 pct, vs Nikkei ... demand growth centred on influenza and cancer treatments. We do not make any influenza drug ... Among such drugs, Takeda's best-selling diabetes drug, Actos, will lose its U.S. patent protection towards ...


1 - 15 / 28      NEXT >>>

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS ACTOS NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

send press release
EIN PRESSWIRE

Press Release Distribution Service
see all health press releases »see all press releases »

list your company
EINDIRECTORY

add listing
EINEVENTS

get free trial
EINNEWS PUBLICATIONS

FORMATS: RSS

EIN News Columnists

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Health Industry News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Science & Technology News

MORE ARTICLES >>>

Take This Poll

According to the White House, 650,000 jobs were created or saved by $150 billion in stimulus funds. Was it money well spent? (Oct. 30, 2009)



 
FORMATS: RSS | EMAIL

Health Insurance News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Health Regulation News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Public Health News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Drugs News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Cancer News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Disease News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Nutrition News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Aging News

MORE ARTICLES >>>

Healthcare Industry Today

Health & Healthcare News Sections
Drugs & Pharmaceuticals News Sections
Health News by Region
Health News by Country
Health News by U.S. State

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

ALL NEWS PUBLICATIONS

You are currently reading Healthcare Industry Today, an EIN News publication.

EIN News provides breaking news coverage on the following topics:

Regional / Politics
Barack Obama
Central Europe
China
EU Politics
Hillary Clinton
International Development
Military
Russia
US Politics
World News
Automotive
Automotive
Electric Cars
Hybrid Cars
Trucks		 Energy
Biofuels
Electric Power
Energy
Ethanol
Geothermal Power
Nuclear Power
Oil & Gas
Power Plants
Renewable Energy
Solar Energy
Wind Energy
Health / Pharmaceuticals
Brain Cancer
Breast Cancer
Health
Lung Cancer
Pharmaceuticals
Prostate Cancer		 Business / Finance
Banking
Conferences
Employment
FOREX Trading
Finance
Gold
International Trade
Investing
Marketing
Real Estate
Science / Technology
Biotechnology
Environment
Global Warming
IT
Nanotechnology
Semiconductors
Software
Technology		 Culture / Society / Lifestyle
Consumer
Human Rights
Media
Movies
Music
Religion
Travel
Company Daily Reports
Airbus
BP Energy
Boeing
Coca-Cola
ConocoPhillips
Exxon Mobil
Gazprom
Pepsi-Cola
Shell Energy
Starbucks		 Industry
Agriculture
Airlines
Chemicals
Cosmetics
Mining
Mobile Phone
Patents & Trademarks
Shipping & Logistics
Textiles
Tobacco
Waste Management
Food / Beverages
Beverages
Fast Food
Food Industry
Food Safety
Organic Food
Seafood

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.

EIN News © 1995 - 2009 IPD Group, Inc. All Rights Reserved. | User Agreement | Privacy Policy | Contact